IL6 and heart failure: As a retrospective study, one of the primary limitations is the lack of routine evaluation of biomarkers such as lactate dehydrogenase (LDH), ferritin, and IL-6 in patients without chronic cardiovascular conditions, e.g., coronary syndrome or heart failure.